Stellular Bio
0 followers
About Stellular Bio
Stellular Bio is a biopharmaceutical company focused on regenerative medicine for ocular surface disease. The company develops platelet-derived regenerative biologic (PRB) therapeutics and aims to bring their lead candidate STLR-201 into clinical testing, with scalable manufacturing to support trials and eventual commercial production. Their work centers on leveraging platelet-derived factors to restore tear film and ocular surface health, targeting Sjogren's syndrome-related dry eye and broader ocular surface disorders in the United States. The team highlights a combination of polypharmacology from platelets and engineered product customization to enable off-the-shelf solutions.